Changing epidemiology of invasive Haemophilus influenzae in Ontario, Canada: evidence for herd effects and strain replacement due to Hib vaccination.
暂无分享,去创建一个
D. Fisman | D. Low | S. Richardson | F. Jamieson | H. Adam | P. Rawte | Don E. Low | S. Richardson
[1] M. Ulanova,et al. Invasive Haemophilus influenzae Disease Caused by Non – Type b Strains in Northwestern Ontario , Canada , 2002 – 2008 , 2009 .
[2] M. Ulanova,et al. Invasive Haemophilus influenzae disease: changing epidemiology and host-parasite interactions in the 21st century. , 2009, Infection, genetics and evolution : journal of molecular epidemiology and evolutionary genetics in infectious diseases.
[3] D. Fisman,et al. Rapid identification of herd effects with the introduction of serogroup C meningococcal conjugate vaccine in Ontario, Canada, 2000-2006. , 2009, Vaccine.
[4] C. Whitney,et al. Optimising the use of conjugate vaccines to prevent disease caused by Haemophilus influenzae type b, Neisseria meningitidis and Streptococcus pneumoniae. , 2008, Vaccine.
[5] S. Halperin,et al. Ongoing Control of Haemophilus influenzae Type B Infections in Canadian Children, 2004–2007 , 2008, The Pediatric infectious disease journal.
[6] Simon G Thompson,et al. Why and how Sources of Heterogeneity Should be Investigated , 2008 .
[7] S. Halperin,et al. Invasive Infections Caused by Haemophilus influenzae Serotypes in Twelve Canadian IMPACT Centers, 1996–2001 , 2007, The Pediatric infectious disease journal.
[8] M. Dworkin,et al. The Changing Epidemiology of Invasive Haemophilus influenzae Disease, Especially in Persons ⩾65 Years Old , 2007 .
[9] J. Wylie,et al. Invasive Haemophilus influenzae in Manitoba, Canada, in the Postvaccination Era , 2006, Journal of Clinical Microbiology.
[10] J. Campos,et al. Analysis of Invasive Haemophilus influenzae Infections after Extensive Vaccination against H. influenzae Type b , 2004, Journal of Clinical Microbiology.
[11] M. Melbye,et al. Impact of routine vaccination with a conjugate Haemophilus influenzae type b vaccine. , 2004, Vaccine.
[12] J. Campos,et al. Antibiotic resistance and clinical significance of Haemophilus influenzae type f. , 2003, The Journal of antimicrobial chemotherapy.
[13] Douglas G. Altman,et al. Systematic reviews in health care : meta-analysis in context , 2008 .
[14] R. Singleton,et al. Invasive Haemophilus influenzae disease in Alaskan residents aged 10 years and older before and after infant vaccination programs. , 2000, JAMA.
[15] H. Peltola. Worldwide Haemophilus influenzae type b disease at the beginning of the 21st century: global analysis of the disease burden 25 years after the use of the polysaccharide vaccine and a decade after the advent of conjugates. , 2000, Clinical microbiology reviews.
[16] J. Sciberras. Invasive Haemophilus influenzae serotype B surveillance in Ontario--documenting the progression towards elimination. , 1999, Canada communicable disease report = Releve des maladies transmissibles au Canada.
[17] M. Szklo,et al. Epidemiology: Beyond the Basics , 1999 .
[18] E. Anis,et al. Effectiveness of a nationwide infant immunization program against Haemophilus influenzae b. The Israeli Pediatric Bacteremia and Meningitis Group. , 1999, Vaccine.
[19] P. Aavitsland,et al. Perspective: a five-country analysis of the impact of four different Haemophilus influenzae type b conjugates and vaccination strategies in Scandinavia. , 1999, The Journal of infectious diseases.
[20] M. Lipsitch,et al. Vaccination against colonizing bacteria with multiple serotypes. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[21] M. Barbour,et al. Conjugate vaccines and the carriage of Haemophilus influenzae type b. , 1996, Emerging infectious diseases.
[22] M. Farley,et al. Invasive disease due to Haemophilus influenzae serotype f: clinical and epidemiologic characteristics in the H. influenzae serotype b vaccine era. The Haemophilus influenzae Study Group. , 1996, Clinical infectious diseases : an official publication of the Infectious Diseases Society of America.
[23] D. Crook,et al. Haemophilus influenzae type b carriage and immunity four years after receiving the Haemophilus influenzae oligosaccharide‐CRM197 (HbOC) conjugate vaccine , 1993, The Pediatric infectious disease journal.
[24] M. Leinonen,et al. Reduction of oropharyngeal carriage of Haemophilus influenzae type b (Hib) in children immunized with an Hib conjugate vaccine. , 1991, The Journal of infectious diseases.
[25] Ellen Jo Baron,et al. Manual of clinical microbiology , 1975 .